Tapewire

NYSE · USD

UHS

UNIVERSAL HEALTH SERVICES INC

Export transactions ↓
Tapewire entity
3529
SEC CIK
0000352915
Parsed reports
280

Last 12 months

Inside the activity.

0 purchase rows · 4 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202502
Dec 202500
Jan 202600
Feb 202600
Mar 202602
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 12, 2026 Filed Mar 13, 2026 20:36 UTC
MILLER ALAN BDirector · Executive Chairman · 10% owner
GrantClass B Common Stock 33,149 $0.00 $0.00
Disclosure

SEC source: 0000352915-26-000013 · form4.xml · nonDerivative · entry 1

MILLER ALAN B · CIK 0001181031 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,797,634

F1 · kind: Represents shares of Class B Common Stock issued upon the vesting of the performance-based restricted stock units ("RSUs") awarded to the Reporting Person on March 15, 2023, which vested based on the Issuer's satisfaction of certain performance criteria. In light of the performance-based vesting criteria of the RSUs, such shares were not previously reportable under Section 16.

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:32 UTC
Miller Marc DDirector · President and CEO
Exercise / conversionOption To Purchase Class B Common Stock · Derivative 50,425 $0.00 Strike: $152.68 $0.00
Disclosure

SEC source: 0000352915-26-000011 · form4.xml · derivative · entry 13

Miller Marc D · CIK 0001315495 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 50,425 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:32 UTC
Miller Marc DDirector · President and CEO
Exercise / conversionOption To Purchase Class B Common Stock · Derivative 50,000 $0.00 Strike: $138.80 $0.00
Disclosure

SEC source: 0000352915-26-000011 · form4.xml · derivative · entry 12

Miller Marc D · CIK 0001315495 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 50,000 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:32 UTC
Miller Marc DDirector · President and CEO
Tax withholdingClass B Common Stock 24,805 $190.49 $4,725,104.45
Disclosure

SEC source: 0000352915-26-000011 · form4.xml · nonDerivative · entry 5

Miller Marc D · CIK 0001315495 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 363,907

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:32 UTC
Miller Marc DDirector · President and CEO
GrantClass B Common Stock 63,036 $0.00 $0.00
Disclosure

SEC source: 0000352915-26-000011 · form4.xml · nonDerivative · entry 4

Miller Marc D · CIK 0001315495 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 388,712

F1 · kind: Represents shares of Class B Common Stock issued upon the vesting of the performance-based restricted stock units ("RSUs") awarded to the Reporting Person on March 15, 2023, which vested based on the Issuer's satisfaction of certain performance criteria. In light of the performance-based vesting criteria of the RSUs, such shares were not previously reportable under Section 16.

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:32 UTC
Miller Marc DDirector · President and CEO
Tax withholdingClass B Common Stock 86,045 $190.83 $16,419,537.13
Disclosure

SEC source: 0000352915-26-000011 · form4.xml · nonDerivative · entry 3

Miller Marc D · CIK 0001315495 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 325,676

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:32 UTC
Miller Marc DDirector · President and CEO
Exercise / conversionClass B Common Stock 50,425 $152.68 $7,698,889.00
Disclosure

SEC source: 0000352915-26-000011 · form4.xml · nonDerivative · entry 2

Miller Marc D · CIK 0001315495 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 411,721

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:32 UTC
Miller Marc DDirector · President and CEO
Exercise / conversionClass B Common Stock 50,000 $138.80 $6,940,000.00
Disclosure

SEC source: 0000352915-26-000011 · form4.xml · nonDerivative · entry 1

Miller Marc D · CIK 0001315495 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 361,296

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:29 UTC
FILTON STEVEExecutive Vice President & CFO
Exercise / conversionOption To Purchase Class B Common Stock · Derivative 44,037 $0.00 Strike: $152.68 $0.00
Disclosure

SEC source: 0000352915-26-000009 · form4.xml · derivative · entry 9

FILTON STEVE · CIK 0001181033 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 44,037 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:29 UTC
FILTON STEVEExecutive Vice President & CFO
Exercise / conversionOption To Purchase Class B Common Stock · Derivative 39,200 $0.00 Strike: $138.80 $0.00
Disclosure

SEC source: 0000352915-26-000009 · form4.xml · derivative · entry 8

FILTON STEVE · CIK 0001181033 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 39,200 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:29 UTC
FILTON STEVEExecutive Vice President & CFO
Tax withholdingClass B Common Stock 6,818 $190.49 $1,298,760.82
Disclosure

SEC source: 0000352915-26-000009 · form4.xml · nonDerivative · entry 5

FILTON STEVE · CIK 0001181033 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,212

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:29 UTC
FILTON STEVEExecutive Vice President & CFO
GrantClass B Common Stock 16,044 $0.00 $0.00
Disclosure

SEC source: 0000352915-26-000009 · form4.xml · nonDerivative · entry 4

FILTON STEVE · CIK 0001181033 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,030

F1 · kind: Represents shares of Class B Common Stock issued upon the vesting of the performance-based restricted stock units ("RSUs") awarded to the Reporting Person on March 15, 2023, which vested based on the Issuer's satisfaction of certain performance criteria. In light of the performance-based vesting criteria of the RSUs, such shares were not previously reportable under Section 16.

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:29 UTC
FILTON STEVEExecutive Vice President & CFO
Tax withholdingClass B Common Stock 71,752 $192.28 $13,796,474.56
Disclosure

SEC source: 0000352915-26-000009 · form4.xml · nonDerivative · entry 3

FILTON STEVE · CIK 0001181033 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,986

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:29 UTC
FILTON STEVEExecutive Vice President & CFO
Exercise / conversionClass B Common Stock 44,037 $152.68 $6,723,569.16
Disclosure

SEC source: 0000352915-26-000009 · form4.xml · nonDerivative · entry 2

FILTON STEVE · CIK 0001181033 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 201,738

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 12, 2026 Filed Mar 13, 2026 20:29 UTC
FILTON STEVEExecutive Vice President & CFO
Exercise / conversionClass B Common Stock 39,200 $138.80 $5,440,960.00
Disclosure

SEC source: 0000352915-26-000009 · form4.xml · nonDerivative · entry 1

FILTON STEVE · CIK 0001181033 · Executive Vice President & CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,701

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 20:11 UTC Exercise / conversionOption To Purchase Class B Common Stock · Derivative 1,250 $0.00 Strike: $138.80 $0.00
Disclosure

SEC source: 0000352915-26-000004 · form4.xml · derivative · entry 7

SUSSMAN ELLIOT J MD MBA · CIK 0001181000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,250

Underlying: Class B Common Stock · 1,250 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 20:11 UTC SaleClass B Common Stock 318 $186.35 $59,257.87
Disclosure

SEC source: 0000352915-26-000004 · form4.xml · nonDerivative · entry 3

SUSSMAN ELLIOT J MD MBA · CIK 0001181000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,113

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.28 to $186.365, inclusive. The reporting person undertakes to provide Universal Health Services, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1.

Read SEC document
March 11, 2026 Filed Mar 13, 2026 20:11 UTC Tax withholdingClass B Common Stock 932 $186.28 $173,612.96
Disclosure

SEC source: 0000352915-26-000004 · form4.xml · nonDerivative · entry 2

SUSSMAN ELLIOT J MD MBA · CIK 0001181000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,431

Read SEC document
March 11, 2026 Filed Mar 13, 2026 20:11 UTC Exercise / conversionClass B Common Stock 1,250 $138.80 $173,500.00
Disclosure

SEC source: 0000352915-26-000004 · form4.xml · nonDerivative · entry 1

SUSSMAN ELLIOT J MD MBA · CIK 0001181000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,363

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 20:06 UTC
MILLER ALAN BDirector · Executive Chairman · 10% owner
Exercise / conversionOption To Purchase Class B Common Stock · Derivative 70,212 $0.00 Strike: $152.68 $0.00
Disclosure

SEC source: 0000352915-26-000002 · form4.xml · derivative · entry 15

MILLER ALAN B · CIK 0001181031 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 70,212 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 20:06 UTC
MILLER ALAN BDirector · Executive Chairman · 10% owner
Exercise / conversionOption To Purchase Class B Common Stock · Derivative 62,500 $0.00 Strike: $138.80 $0.00
Disclosure

SEC source: 0000352915-26-000002 · form4.xml · derivative · entry 14

MILLER ALAN B · CIK 0001181031 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 62,500 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 20:06 UTC
MILLER ALAN BDirector · Executive Chairman · 10% owner
Tax withholdingClass B Common Stock 114,258 $189.62 $21,665,601.96
Disclosure

SEC source: 0000352915-26-000002 · form4.xml · nonDerivative · entry 3

MILLER ALAN B · CIK 0001181031 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,764,485

Read SEC document
March 10, 2026 Filed Mar 11, 2026 20:06 UTC
MILLER ALAN BDirector · Executive Chairman · 10% owner
Exercise / conversionClass B Common Stock 70,212 $152.68 $10,719,968.16
Disclosure

SEC source: 0000352915-26-000002 · form4.xml · nonDerivative · entry 2

MILLER ALAN B · CIK 0001181031 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,878,743

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 10, 2026 Filed Mar 11, 2026 20:06 UTC
MILLER ALAN BDirector · Executive Chairman · 10% owner
Exercise / conversionClass B Common Stock 62,500 $138.80 $8,675,000.00
Disclosure

SEC source: 0000352915-26-000002 · form4.xml · nonDerivative · entry 1

MILLER ALAN B · CIK 0001181031 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,808,531

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
November 11, 2025 Filed Nov 12, 2025 13:24 UTC Exercise / conversionOption To Purchase Class B Common Stock · Derivative 10,000 $0.00 Strike: $138.80 $0.00
Disclosure

SEC source: 0000352915-25-000013 · form4.xml · derivative · entry 5

Nimetz Warren J. · CIK 0001728690 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 10,000 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
November 11, 2025 Filed Nov 12, 2025 13:24 UTC SaleClass B Common Stock 142 $223.96 $31,801.79
Disclosure

SEC source: 0000352915-25-000013 · form4.xml · nonDerivative · entry 4

Nimetz Warren J. · CIK 0001728690 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,481

F2 · kind: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $223.93 to $223.99, inclusive. The reporting person undertakes to provide Universal Health Services, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 2.

Read SEC document
November 11, 2025 Filed Nov 12, 2025 13:24 UTC SaleClass B Common Stock 3,675 $223.28 $820,541.51
Disclosure

SEC source: 0000352915-25-000013 · form4.xml · nonDerivative · entry 3

Nimetz Warren J. · CIK 0001728690 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,623

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $222.92 to $223.91, inclusive. The reporting person undertakes to provide Universal Health Services, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1.

Read SEC document
November 11, 2025 Filed Nov 12, 2025 13:24 UTC Tax withholdingClass B Common Stock 6,183 $224.49 $1,388,021.67
Disclosure

SEC source: 0000352915-25-000013 · form4.xml · nonDerivative · entry 2

Nimetz Warren J. · CIK 0001728690 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,298

Read SEC document
November 11, 2025 Filed Nov 12, 2025 13:24 UTC Exercise / conversionClass B Common Stock 10,000 $138.80 $1,388,000.00
Disclosure

SEC source: 0000352915-25-000013 · form4.xml · nonDerivative · entry 1

Nimetz Warren J. · CIK 0001728690 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,481

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:34 UTC
Peterson Matthew JayExecutive Vice President, UHS
Exercise / conversionOption To Purchase Class B Common Stock · Derivative 9,465 $0.00 Strike: $152.68 $0.00
Disclosure

SEC source: 0000352915-25-000011 · form4.xml · derivative · entry 5

Peterson Matthew Jay · CIK 0001788925 · Executive Vice President, UHS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 9,465 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:34 UTC
Peterson Matthew JayExecutive Vice President, UHS
Exercise / conversionOption To Purchase Class B Common Stock · Derivative 8,425 $0.00 Strike: $138.80 $0.00
Disclosure

SEC source: 0000352915-25-000011 · form4.xml · derivative · entry 4

Peterson Matthew Jay · CIK 0001788925 · Executive Vice President, UHS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 8,425 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:34 UTC
Peterson Matthew JayExecutive Vice President, UHS
Tax withholdingClass B Common Stock 14,312 $225.15 $3,222,346.80
Disclosure

SEC source: 0000352915-25-000011 · form4.xml · nonDerivative · entry 3

Peterson Matthew Jay · CIK 0001788925 · Executive Vice President, UHS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,957.5817

F1 · balance_after: Includes 583.5817 shares purchased at a discounted rate pursuant to the Universal Health Services 2005 Employee Stock Purchase Plan.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:34 UTC
Peterson Matthew JayExecutive Vice President, UHS
Exercise / conversionClass B Common Stock 9,465 $152.68 $1,445,116.20
Disclosure

SEC source: 0000352915-25-000011 · form4.xml · nonDerivative · entry 2

Peterson Matthew Jay · CIK 0001788925 · Executive Vice President, UHS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,269.5817

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 583.5817 shares purchased at a discounted rate pursuant to the Universal Health Services 2005 Employee Stock Purchase Plan.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:34 UTC
Peterson Matthew JayExecutive Vice President, UHS
Exercise / conversionClass B Common Stock 8,425 $138.80 $1,169,390.00
Disclosure

SEC source: 0000352915-25-000011 · form4.xml · nonDerivative · entry 1

Peterson Matthew Jay · CIK 0001788925 · Executive Vice President, UHS

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,804.5817

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 583.5817 shares purchased at a discounted rate pursuant to the Universal Health Services 2005 Employee Stock Purchase Plan.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:23 UTC Exercise / conversionOption To Purchase Class B Common Stock · Derivative 2,500 $0.00 Strike: $138.80 $0.00
Disclosure

SEC source: 0000352915-25-000009 · form4.xml · derivative · entry 4

SUSSMAN ELLIOT J MD MBA · CIK 0001181000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Class B Common Stock · 2,500 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:23 UTC SaleClass B Common Stock 965 $225.70 $217,798.67
Disclosure

SEC source: 0000352915-25-000009 · form4.xml · nonDerivative · entry 3

SUSSMAN ELLIOT J MD MBA · CIK 0001181000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,113

F1 · kind: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $225.38 to $225.80, inclusive. The reporting person undertakes to provide Universal Health Services, Inc. (the "Company"), any stockholder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnote 1.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:23 UTC Tax withholdingClass B Common Stock 1,535 $226.15 $347,140.25
Disclosure

SEC source: 0000352915-25-000009 · form4.xml · nonDerivative · entry 2

SUSSMAN ELLIOT J MD MBA · CIK 0001181000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,078

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:23 UTC Exercise / conversionClass B Common Stock 2,500 $138.80 $347,000.00
Disclosure

SEC source: 0000352915-25-000009 · form4.xml · nonDerivative · entry 1

SUSSMAN ELLIOT J MD MBA · CIK 0001181000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,613

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:14 UTC
Miller Marc DDirector · President and CEO
Exercise / conversionOption To Purchase Class B Common Stock · Derivative 90,000 $0.00 Strike: $152.68 $0.00
Disclosure

SEC source: 0000352915-25-000005 · form4.xml · derivative · entry 11

Miller Marc D · CIK 0001315495 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,425

Underlying: Class B Common Stock · 90,000 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:14 UTC
Miller Marc DDirector · President and CEO
Exercise / conversionOption To Purchase Class B Common Stock · Derivative 75,000 $0.00 Strike: $138.80 $0.00
Disclosure

SEC source: 0000352915-25-000005 · form4.xml · derivative · entry 10

Miller Marc D · CIK 0001315495 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Class B Common Stock · 75,000 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:14 UTC
Miller Marc DDirector · President and CEO
Tax withholdingClass B Common Stock 131,758 $225.30 $29,685,077.40
Disclosure

SEC source: 0000352915-25-000005 · form4.xml · nonDerivative · entry 3

Miller Marc D · CIK 0001315495 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 311,296

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:14 UTC
Miller Marc DDirector · President and CEO
Exercise / conversionClass B Common Stock 90,000 $152.68 $13,741,200.00
Disclosure

SEC source: 0000352915-25-000005 · form4.xml · nonDerivative · entry 2

Miller Marc D · CIK 0001315495 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 443,054

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:14 UTC
Miller Marc DDirector · President and CEO
Exercise / conversionClass B Common Stock 75,000 $138.80 $10,410,000.00
Disclosure

SEC source: 0000352915-25-000005 · form4.xml · nonDerivative · entry 1

Miller Marc D · CIK 0001315495 · Director · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 353,054

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:10 UTC
MILLER ALAN BDirector · Executive Chairman · 10% owner
Exercise / conversionOption To Purchase Class B Common Stock · Derivative 62,500 $0.00 Strike: $138.80 $0.00
Disclosure

SEC source: 0000352915-25-000003 · form4.xml · derivative · entry 15

MILLER ALAN B · CIK 0001181031 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,500

Underlying: Class B Common Stock · 62,500 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:10 UTC
MILLER ALAN BDirector · Executive Chairman · 10% owner
Exercise / conversionOption To Purchase Class B Common Stock · Derivative 70,213 $0.00 Strike: $152.68 $0.00
Disclosure

SEC source: 0000352915-25-000003 · form4.xml · derivative · entry 14

MILLER ALAN B · CIK 0001181031 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,212

Underlying: Class B Common Stock · 70,213 shares

Expires 2026-03-16

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: Option vested ratably on each of 3/17/2022, 3/17/2023, 3/17/2024 and 3/17/2025.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:10 UTC
MILLER ALAN BDirector · Executive Chairman · 10% owner
Tax withholdingClass B Common Stock 105,519 $227.04 $23,957,033.76
Disclosure

SEC source: 0000352915-25-000003 · form4.xml · nonDerivative · entry 3

MILLER ALAN B · CIK 0001181031 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,746,031

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:10 UTC
MILLER ALAN BDirector · Executive Chairman · 10% owner
Exercise / conversionClass B Common Stock 62,500 $138.80 $8,675,000.00
Disclosure

SEC source: 0000352915-25-000003 · form4.xml · nonDerivative · entry 2

MILLER ALAN B · CIK 0001181031 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,851,550

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
October 29, 2025 Filed Oct 30, 2025 20:10 UTC
MILLER ALAN BDirector · Executive Chairman · 10% owner
Exercise / conversionClass B Common Stock 70,213 $152.68 $10,720,120.84
Disclosure

SEC source: 0000352915-25-000003 · form4.xml · nonDerivative · entry 1

MILLER ALAN B · CIK 0001181031 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,789,050

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 06, 2025 Filed Aug 7, 2025 13:04 UTC
MILLER ALAN BDirector · Executive Chairman · 10% owner
OtherClass B Common Stock 83,252 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-020204 · form4.xml · nonDerivative · entry 9

MILLER ALAN B · CIK 0001181031 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,718,837

F2 · kind: Includes 83,252 shares of Class B Common Stock received as liquidating distribution from each of MS 2014 LLC and AMK 2014 LLC (the "2014 LLCs") to the reporting person in proportion to his interest in the 2014 LLCs. This transaction represents a change in the form of ownership from indirect to direct, with no change in the reporting person's pecuniary interest in the securities. Other than the shares distributed to the reporting person, the reporting person disclaims any pecuniary interest in the shares previously held by the 2014 LLCs, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document
August 06, 2025 Filed Aug 7, 2025 13:04 UTC
MILLER ALAN BDirector · Executive Chairman · 10% owner
OtherClass B Common Stock 83,252 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-020204 · form4.xml · nonDerivative · entry 8

MILLER ALAN B · CIK 0001181031 · Director · Executive Chairman · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,635,585

F2 · kind: Includes 83,252 shares of Class B Common Stock received as liquidating distribution from each of MS 2014 LLC and AMK 2014 LLC (the "2014 LLCs") to the reporting person in proportion to his interest in the 2014 LLCs. This transaction represents a change in the form of ownership from indirect to direct, with no change in the reporting person's pecuniary interest in the securities. Other than the shares distributed to the reporting person, the reporting person disclaims any pecuniary interest in the shares previously held by the 2014 LLCs, and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.